Experts and professionals from different sectors involved in the prevention and treatment of Legionella, both from the public administration and private companies, met this week in the Espaitec 2 building of the Scientific, Technological and Business Park of the Universitat Jaume I of Castellón to attend the technical conference on immunomagnetic separation (SIM) technology applied to the prevention of legionellosis, organized by Biotics Biochemistry Analytical SL.?

The Castellón company has developed the rapid test Legipid®, increasingly used for the detection and quantification of Legionella in water samples and, during the session, the commercial director, Mireia Lazaro, as well as the scientific director of the firm, Guillermo Rodriguez, announced the latest advances that this project has experienced in a day moderated by Begoña Bedrina, member of the commercial technical department.

Biotica-Day-SIM-Legionella-2As for the rest of the presentations, Sergi Martí, president of AquaEspaña, spoke about the entry into force of the UNE 100030:2017 Standard on Prevention and control of the proliferation and dissemination of Legionella in facilities, which establishes a new regulatory framework that allows raising voluntarily professional standards in the sector to guarantee that service companies have the technical solvency that guarantees due protection of public health. This standard, complementary to the current Royal Decree RD865/2003, contemplates the use of validated and certified methods, such as immunomagnetic separation.

For his part, Jesús Laso, manager of the Quality Services Office, and Inmaculada Solís, head of Microbiology at Iproma, defined the simple guidelines and procedures for accredited laboratories to incorporate the test. In turn, Juan Carlos Montero, head of Environmental and Clinical Microbiology at the Institute of Health Sciences of Talavera de la Reina, explained the important role that the Legipid® test has had in the control of legionellosis outbreaks.

The day, which was inaugurated by the academic director of Espaitec-UJI, David Cabedo, concluded with a practical session in which attendees were able to verify the simplicity of use of this detection method, in addition to sharing experiences and applications of the Legipid rapid test. ®.

Following the success of the call, Biotica will soon organize new editions of this event both in Castellón and in other cities in Spain, which will be held in the coming months. In turn, the video of the day can be viewed shortly on the Biotica website.

More information: www.biotica.es /info@biotica.es/ 964 108 131

Experts and professionals from the different sectors involved in preventing and treating Legionella, in both public administrations and private companies, met this week in the espaitec 2 building at the Science, Technology and Business Park of the Universitat Jaume I in Castellón to attend a technical conference about immunomagnetic separation (IMS) technology applied to prevent Legionnaires' Disease, organized by Biotics Biochemistry Analytical SL.

This company, based in the city of Castellón, you have developed the rapid Legipid® test, which is being increasingly used to detect and quantify Legionella in water samples. During this session, this company's sales manager, Mireia Lazaro, and the Head of Science, Guillermo Rodriguez, informed about the latest advances made in this project during the event chaired by Begoña Bedrina, a member of the commercial technical department.

Biotica-Day-SIM-Legionella-2Sergi Martí, the AquaEspaña President, talked about Standard UNE 100030:2017, on the Prevention and Control of the Proliferation and Spread of Legionella in facilities coming into force, which allows levels of the professional standards in the sector to voluntarily rise to ensure that services companies are technically sound to duly guarantee public health protection. This standard complements Royal Decree RD865/2003, currently in force, which contemplates the use of validated and certified methods, which is the case of IMS.

Jesús Laso, the Manager of the Office of Services for Quality, and Inmaculada Solís, Head of Microbiology at Iproma, defined the simple patterns and procedures that allow accredited laboratories to include this test. Juan Carlos Montero, Head of Environmental and Clinical Microbiology at the Talavera de la Reina Health Sciences Institute, explained the key role that the Legipid® test plays in controlling outbreaks of Legionnaires' Disease.

This event, which was opened by espaitec-UJI Academic Director, David Cabedo, ended with a practical session in which those who attended were able to check for themselves the simple use of this detection method, and could share rapid Legipid® test experiences and applications .

Following this successful event, BiÓtica will soon organize new editions of this event in Castellón and other Spanish cities, which are to be held in the coming months. The video of this event will soon be available on Biotica's website.

More information at: www.biotica.es /info@biotica.es/ Tel. No. + 34 964 108 131

WEBSITE FINANCED BY: